Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 6
2016 3
2017 2
2018 4
2019 3
2020 3
2021 4
2022 2
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yuanqing xu[Author] (63 results)?
Oral lichen planus: comparative efficacy and treatment costs-a systematic review.
Sandhu S, Klein BA, Al-Hadlaq M, Chirravur P, Bajonaid A, Xu Y, Intini R, Hussein M, Vacharotayangul P, Sroussi H, Treister N, Sonis S. Sandhu S, et al. Among authors: xu y. BMC Oral Health. 2022 May 6;22(1):161. doi: 10.1186/s12903-022-02168-4. BMC Oral Health. 2022. PMID: 35524296 Free PMC article.
CRISPR screen in regulatory T cells reveals modulators of Foxp3.
Cortez JT, Montauti E, Shifrut E, Gatchalian J, Zhang Y, Shaked O, Xu Y, Roth TL, Simeonov DR, Zhang Y, Chen S, Li Z, Woo JM, Ho J, Vogel IA, Prator GY, Zhang B, Lee Y, Sun Z, Ifergan I, Van Gool F, Hargreaves DC, Bluestone JA, Marson A, Fang D. Cortez JT, et al. Among authors: xu y. Nature. 2020 Jun;582(7812):416-420. doi: 10.1038/s41586-020-2246-4. Epub 2020 Apr 29. Nature. 2020. PMID: 32499641 Free PMC article.
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Xu Y, Carrascosa LC, Yeung YA, Chu ML, Yang W, Djuretic I, Pappas DC, Zeytounian J, Ge Z, de Ruiter V, Starbeck-Miller GR, Patterson J, Rigas D, Chen SH, Kraynov E, Boor PP, Noordam L, Doukas M, Tsao D, Ijzermans JN, Guo J, Grünhagen DJ, Erdmann J, Verheij J, van Royen ME, Doornebosch PG, Feldman R, Park T, Mahmoudi S, Dorywalska M, Ni I, Chin SM, Mistry T, Mosyak L, Lin L, Ching KA, Lindquist KC, Ji C, Londono LM, Kuang B, Rickert R, Kwekkeboom J, Sprengers D, Huang TH, Chaparro-Riggers J. Xu Y, et al. Cancer Immunol Res. 2021 Oct;9(10):1141-1157. doi: 10.1158/2326-6066.CIR-21-0058. Epub 2021 Aug 10. Cancer Immunol Res. 2021. PMID: 34376502
Oral Complications from Oropharyngeal Cancer Therapy.
Sankar V, Xu Y. Sankar V, et al. Among authors: xu y. Cancers (Basel). 2023 Sep 14;15(18):4548. doi: 10.3390/cancers15184548. Cancers (Basel). 2023. PMID: 37760517 Free PMC article. Review.
Thalidomide for management of refractory oral mucosal diseases.
Xu Y, Woo SB, Treister NS. Xu Y, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Apr;137(4):372-378. doi: 10.1016/j.oooo.2023.12.793. Epub 2024 Jan 9. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024. PMID: 38388332
32 results